Insight Molecular Diagnostics Inc (IMDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 250 | 100 |
| Marketable Securities | 3,280 | 4,630 |
| Other current assets | 120 | 120 |
| TOTAL | $3,650 | $4,850 |
| Non-Current Assets | ||
| PPE Net | 250 | 240 |
| Other Non-Current Assets | 2,580 | 3,280 |
| TOTAL | $2,830 | $3,520 |
| Total Assets | $5,240 | $8,280 |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 140 | 100 |
| Accrued Expenses | 280 | 30 |
| Other current liabilities | 5,880 | 2,960 |
| TOTAL | $6,310 | $4,670 |
| Non-Current Liabilities | ||
| TOTAL | $N/A | $N/A |
| Total Liabilities | $6,310 | $4,670 |
| Shareholders' Equity | ||
| Common Shares | 15,140 | 15,390 |
| Retained earnings | -15,390 | -10,410 |
| Other shareholders' equity | -820 | -1,370 |
| TOTAL | $-1,070 | $3,610 |
| Total Liabilities And Equity | $5,240 | $8,280 |